Preeclampsia is a systemic disease of pregnancy characterized by maternal hypertension, proteinuria, and edema. These clinical pathological findings may be attributed to abnormalities in vascular endothelial activation secondary to increased oxidative stress. To test the hypothesis that increased circulating lipid peroxides in preeclamptic women activate vascular endothelial cells, we determined NF-κB transcriptional activity and ICAM-1 expression in human umbilical vein endothelial cells (HUVEC) cultured with plasma from women with severe preeclampsia (preeclamptic plasma, N = 12) or plasma from normal pregnancies (normal plasma, N = 12). Preeclamptic women had increased circulating lipid peroxides compared with normal pregnant women, as demonstrated by a 4.5-fold higher concentration of plasma malondialdehyde (P<0.001). By using a NF-κB luciferase reporter construct transfected into HUVEC, preeclamptic plasma was found to up-regulate HUVEC NF-κB activity by 2.5-fold when compared with normal plasma (P<0.001). Inhibition of lipid peroxides with both vitamin E and N-acetyl-cysteine significantly reduced NF-κB activation in response to preeclamptic-plasma by 77% (P<0.005) and 76% (P<0.01), respectively. Flow cytometric analysis revealed that preeclamptic-plasma also up-regulated HUVEC ICAM-1 expression by 30% (P<0.001) compared with normal-plasma, while both vitamin E (P<0.005) and N-acetyl-cysteine (P<0.0001) significantly inhibited this effect. In summary, elevated plasma levels of lipid peroxides in preeclampsia are associated with increased NF-κB activation and ICAM-1 expression on HUVEC, which can be inhibited by vitamin E and N-acetyl-cysteine.
Evidence for endothelial cell activation and dysfunction in preeclampsia includes increased circulating levels of factor VIII antigen, cellular fibronectin, and endothelial-derived adhesion molecules, including soluble intracellular adhesion molecule-1 (ICAM-1) (3) (4) (5) . Maternal risk factors for the development of preeclampsia are very similar to those associated with arteriosclerosis, including obesity, hypertension, insulin resistance, and hyperlipidemia (6, 7) . Consequently, most investigators agree that the pathogenic mechanisms of preeclampsia, as in arteriosclerosis, converge on the vascular endothelium resulting in endothelial activation and dysfunction.
A significant pathogenic mechanism leading to endothelial cell activation and dysfunction in preeclampsia may be attributed to increased oxidative stress. During normal pregnancy, the placenta is known to produce significant quantities of reactive oxygen species and lipid peroxides (8) . In women at risk for preeclampsia, the ability of the antioxidant system to neutralize placental lipid peroxides may be exceeded and a pathologic state of oxidative stress develops. This theory is suggested by the fact that, in preeclampsia, protective antioxidants such as vitamin E are decreased and circulating levels of lipid peroxides are increased (9) (10) (11) . A welldesigned prospective clinical trial demonstrating that vitamin E and vitamin C supplementation decreases the incidence of preeclampsia further supports oxidative stress as a mechanism in the pathogenesis of preeclampsia (12) . Consequently, increased lipid peroxides in preeclampsia may be responsible for endothelial cell activation and dysfunction in this disease (13) . Similarly, increased lipid peroxides and decreased antioxidants are thought to result in endothelial cell activation in the pathogenesis of arteriosclerosis (14, 15) .
A potential mechanism for vascular endothelial activation by increased lipid peroxides in preeclampsia is through the activation of nuclear transcription factor kappa B (NF-κB). NF-κB is a transcription factor that can be activated by lipid peroxides, oxidative stress, and proinflammatory cytokines (16, 17) . Once activated, NF-κB binds to DNA cis-regulatory promotor elements and induces the expression of several pro-inflammatory cytokines such as monocyte chemotactic protein-1 (MCP-1) and interleukin-8 (IL-8), in addition to cellular adhesion molecules such as ICAM-1 (16, 18) . Activation of circulating monocytes by endothelial proinflammatory cytokines, along with increased endothelial ICAM-1 expression, is thought to result in increased monocyte/endothelial cell adherence and the presence of numerous macrophages in atherosclerotic lesions (19, 20) . Preeclampsia is also associated with infiltrating macrophage vascular lesions of the uterine spiral arteries termed "acute atherosis" (21, 22) . Consequently, increased circulating lipid peroxides in preeclampsia could result in endothelial activation of NF-κB stimulating ICAM-1 expression and increased adhesion of activated monocytes. Furthermore, inhibition of NF-κB activation by lipid peroxide with antioxidants such as vitamin E would be expected to down-regulate the expression of endothelial cell ICAM-1 expression (23).
To test whether increased circulating lipid peroxides in preeclamptic women activate NF-κB in vascular endothelial cells and result in the increased expression of ICAM-1, NF-κB transcriptional activity and ICAM-1 expression were determined in human umbilical vein endothelial cells (HUVEC) cultured in the presence of plasma from women with normal and preeclamptic pregnancies. Furthermore, because antioxidant therapy decreases the incidence of preeclampsia in women at high risk, we also determined whether vitamin E or N-acetyl-cysteine could effectively inhibit NF-κB activation and ICAM-1 expression in HUVEC induced by plasma from preeclamptic women.
MATERIAL AND METHODS

Preeclamptic and normal plasma samples
Under approval of the Institutional Internal Review Board of Virginia Commonwealth University, blood samples were collected into standard sodium heparin-coated tubes from women with normal-term pregnancy and from women with severe preeclampsia. Normal pregnant patients were without any chronic or acute physical illness and were not taking any medications. Severe preeclampsia was defined by American College of Obstetrics and Gynecology guidelines and included blood-pressure measurements of 160/110 or higher, proteinuria of 5 g in 24 h or more, thrombocytopenia (100,000/ml or less), oliguria (500 ml in 24 h or less), elevated liver function tests, or seizures (eclampsia) (24) . After centrifugation, the plasma samples were aliquoted and stored at -20°C until further use. Butylated hydroxytoluene, 1-mM final concentration (Sigma Chemical Co., St. Louis, Mo.), was added to the samples used in the malondialdehyde assay to prevent further oxidation.
Isolation, characterization and culture of HUVEC
HUVEC were isolated from fresh-term umbilical cords as previously described (25, 26) . In brief, both ends of the umbilical cord were cannulated with one-way stopcocks and the lumen was perfused with PBS. The lumen was filled with PBS containing 0.1% collagenase (Clostridium hystolyticum, Type I, Sigma) and incubated at 37°C for 15 min. The collagenase solution was flushed into conical tubes by using an equal volume of Hanks' balanced salt solution, and the endothelial cells were pelleted by centrifugation at 200 g for 5 min. The endothelial cells were re-suspended in medium-199 (Sigma) containing 20% FBS (Life Technologies, Gaithersburg, Md.), 20 µg/ml endothelial cell growth supplement (Sigma), 90 µg/ml heparin (Sigma), antibiotic/antimytotic solution (100 U/ml penicillin, 100 µg/ml, streptomycin, 25 µg/ml amphotericin B, Life Technologies) and plated into 0.2% gelatin-coated 25-cm 2 flasks (Corning Incorporated, Corning, N.Y.). Subsequently, the cells were subcultured in F-12K medium (ATCC, Rockville, Md.) with 10% FBS and the same supplements as above. Experiments were performed on cells in the sixth or seventh passages. Isolated cells were characterized as endothelial cells by morphology and Factor VIII staining (26) .
Malondialdehyde assay for lipid peroxides
Malondialdehyde, a breakdown product of lipid peroxides, was measured as previously described (27) . In the presence of heat and acid, malondialdehyde reacts with thiobarbituric acid to form a red pigment having a peak wavelength of 530 nm (28) (all reagents for this assay were purchased from Sigma). Malondialdehyde standards were prepared by hydrolysis of 1,1,3,3-tetramethhoxypropane. Samples were mixed with 0.2 M phosphoric acid, 5 mM butylated hydroxytoluene, and 0.11 M thiobarbituric acid. Additional BHT (final concentration, 5 mM) was added to the plasma samples to prevent further lipid peroxidation during the heating step. The mixture was incubated at 90°C for 45 min, briefly put on ice, and then allowed to cool to room temperature. Malondialdehyde was extracted with n-butanol, and saturated sodium chloride was added to help phase separation. After centrifugation, the organic phase was transferred to a flat-bottom 96-well plate (Costar Corporation, Cambridge, Mass.). Absorption was measured by using a 96-well plate reader (Spectra, Microplate Autoreader, Tecan, N.C.) at 530 nm and at 570 nm to correct for background absorption. Malondialdehyde equivalents were calculated by using the difference in absorption at the two wavelengths. Significant differences between malondialdehyde levels in normal and preeclamptic plasma samples were determined by using the Student t-test.
NF-κB transcription Luciferase Reporter Assay
HUVEC cells were plated in gelatin-coated 24-well plates. To reach 50%-70% confluence, 15,000 cells were plated to each well in F-12K media with supplements (as mentioned earlier) and 10% FBS. After overnight incubation, the cells were washed with PBS and transfected with both pNFκB-Luc (Stratagene, La Jolla, Calif.) and pRL-TK (Promega, Madison Wisc.) plasmids. The pNFκB-Luc contains the firefly luciferase reporter gene driven by a basic promoter element joined to tandem repeats of NF-κB binding elements, while the pRL-TK contains the renilla luciferase reporter gene. Co-transfection with pRL-TK served as a standard for transfection efficiency. The transfection was carried out in serum-free media with SuperFect (Qiagen, Valencia, Calif.) for 1 h, following the company's protocol. Transfection optimization studies revealed that 1 µg pNFκB-Luc and 20 ng pRL-TK with 2.5 µl of SuperFect per well resulted in the highest transfection rate. After transfection, the medium was changed, and fresh medium with 5% normal or severe preeclamptic plasma was added for 48 h. Firefly luciferase activity from NF-κB was normalized to renilla luciferase activity from pRL-TK. Dual luciferase activity was measured with Dual-Luciferase Reporter Assay (Promega) in a luminometer (Berthold Analytical Instruments Inc., Nashua, N.H.) and the results were expressed as an index of relative light units (RLU). To determine the effect of antioxidant treatment, similar studies were performed with or without the addition of either 5 mM N-acetyl-cysteine in one set of experiments or 50 µM vitamin E (Sigma) in another set of experiments. N-acetyl-cysteine was pH-balanced to 7.4 before it was added to the cells. Statistical analysis was performed with Student's t-test, paired Student's t-test, or Mann-Whitney Rank Sum test, when normality test failed.
Flow Cytometry for ICAM-1
HUVEC were treated with normal or severe preeclamptic plasma for 48 h. After being washed with PBS, the cells were released with the addition of 2 mM EDTA for 5 min. After brief centrifugation, the cells were stained with 20 µg/ml anti-CD54 (ICAM-1) antibody (Pharmingen, San Diego, Calif.) or with an isotype matching non-specific antibody (Pharmingen) in 10% normal goat serum (Life Technologies) with PBS for 30 min on ice. The samples were washed and stained with a 1:100 dilution of biotin-labeled anti-mouse antibody (Vector, Burlingame, Calif.) for 30 min on ice. After the samples were washed, 10 µg/ml streptavidin-FITC (Pharmingen) was added for 30 min on ice. Propidium iodine was used to gate-out dead cells from the flow analysis. The cells were analyzed with a Coulter XL-MCL flow cytometer, by using the same settings for all samples. Gated cells were acquired (5,000 events) and markers were set according to negative control values to quantitate the percentage of positively stained cells. To determine the effect of antioxidant treatment on HUVEC ICAM-1 expression in response to preeclamptic plasma, similar studies were performed with or without the addition of either 5 mM N-acetyl-cysteine or 50 µM vitamin E (Sigma). Statistical analysis was performed with student t-test or paired student t-test.
RESULTS
Patient demographics for the preeclamptic women and normal pregnant women are shown in Table 1 . As expected, the severe preeclamptic patients had significantly higher systolic (P<0.001) and diastolic (P<0.001) blood pressures as well as higher body weight (P<0.01). Urine protein dipstick measurements showed that all of the normal patients had 1+ or less urine protein, whereas 7 of the 12 preeclamptic patients had 2+ or more proteinuria. Although gestational age, birth weight, placental weight, and parity were lower in the preeclamptic patients, these differences did not reach statistical significance with the current population sample size.
Plasma samples from severe preeclamptic patients showed a 4.5-fold higher concentration of malondialdehyde than did normal pregnant patients' samples (Fig. 1) . The significantly higher malondialdehyde (6.12 vs. 1.36 µM, P<0.001) concentration indicates increased circulating levels of lipid peroxides in the preeclamptic patients.
Lipid peroxides and oxidative stress are known to activate NF-κB in a variety of cell types. In HUVEC transfected with the NF-κB luciferase reporter construct, plasma from women with severe preeclampsia up-regulated endothelial NF-κB activity 2.5-fold more than plasma from normal pregnant women (P<0.001, Fig. 2 ). N-acetyl-cysteine and vitamin E, both potent antioxidants, are known inhibitors of NF-κB activation. In HUVEC that was transfected with the NF-κB luciferase reporter construct and treated with severe preeclamptic plasma, vitamin E reduced NF-κB activity by 77% (P<0.005, Fig. 3 ) and N-acetyl-cysteine reduced NF-κB activity by 76% (P<0.01, Fig. 4 ) compared with HUVEC treated with severe preeclamptic plasma alone. In contrast, N-acetyl-cysteine reduced NF-κB activity in HUVEC treated with normal pregnant plasma by only 27%.
ICAM-1 is regulated transcriptionally by NF-κB, and activation of NF-κB results in increased ICAM-1 expression. Flow cytometric analysis revealed that severe preeclamptic plasma significantly up-regulated ICAM-1 cell surface expression compared with that in normal pregnant patients by 30% (P<0.001, Fig. 2) . In experiments to determine the effect of antioxidant treatment on HUVEC ICAM-1 expression in response to severe preeclamptic plasma, both Nacetyl-cysteine and vitamin E reduced ICAM-1 expression significantly. N-acetyl-cysteine reduced ICAM-1 expression by 62% (P<0.0001, Fig. 3 ) and vitamin E, by 39% (P<0.005, Fig. 4 ) compared with HUVEC treated with severe preeclamptic plasma without antioxidants.
DISCUSSION
Preeclampsia is a systemic disease characterized by diffuse endothelial dysfunction, vasospasm, increased oxidative stress, anti-oxidant deficiencies, hyperlipidemia, and activation of the coagulation system (29) (30) (31) (32) . Over the years, various theories have been proposed to explain the pathophysiology of preeclampsia, including vascular endothelial damage, cardiovascular maladaptation, immunologic phenomena, abnormal trophoblast invasion, coagulation abnormalities, genetic predisposition, and dietary deficiencies or excesses (1, (33) (34) (35) . Despite ongoing research into the etiology of preeclampsia, the cause remains unknown. However, most investigators would agree that the pathogenic mechanisms of preeclampsia converge on the vascular endothelium, resulting in endothelial activation and dysfunction. Consequently, most of the clinical pathological findings in preeclampsia, including hypertension, edema, proteinuria and activation of the coagulation system, can be attributed to abnormalities in endothelial function.
A major factor leading to endothelial cell dysfunction in preeclampsia is increased circulating levels of lipid peroxides. Preeclampsia is associated with increased levels of triglycerides and free fatty acids (29, 32, 35, 36) . In a case control study, Kaaja et al. found that women with preeclampsia exhibited 65% higher mean triglyceride levels (7) . The importance of the increased free fatty acids and hypertriglyceridemia is that these compounds can undergo either spontaneous or induced oxidation, which leads to an increase in lipid peroxides and oxidative stress (37) . During normal pregnancy, the placenta produces significant quantities of reactive oxygen species and lipid peroxides (8) . In women with dyslipidemia and increased lipid peroxides, the ability of the antioxidant systems to neutralize placental lipid peroxides is exceeded and a pathologic state of oxidative stress develops. The placental contribution to increased circulating levels of lipid peroxides may serve as the "catalyst" for increased oxidative stress in preeclampsia which, when eliminated at the time of delivery, results in disease regression. Evidence has accumulated that women with preeclampsia have increased circulating levels of oxygen free radicals and lipid peroxides (30) . Conversely, women with preeclampsia have decreased levels of circulating antioxidants such as vitamin E (30).
This study is the first to report that plasma from women with severe preeclampsia activates NF-κB in vascular endothelial cells. Lipid peroxides, oxidative stress, and reactive oxygen intermediates have been shown previously to activate NF-κB in a variety of cell types (16, 38) . Our findings suggest that increased circulating lipid peroxides in preeclamptic women are responsible for endothelial cell NF-κB activation, as plasma samples from preeclamptic women used in these studies had 4.5-fold higher levels of lipid peroxides than those of normal pregnant women. This hypothesis is supported further by the fact that vitamin E and N-acetyl-cysteine, both antioxidants, significantly inhibited endothelial cell NF-κB activation by preeclamptic plasma. Although there was small decrease in NF-kB activity by N-acetyl-cysteine in the normal group without preeclampsia, this finding was probably due to the presence of low levels of lipid peroxides known to be present in the plasma of normal pregnant women (31) .
Circulating levels of soluble ICAM-1 are increased in women with preeclampsia and have been thought to be a marker of endothelial activation in this disease (5, 39) . In addition, circulating soluble ICAM-1 levels are increased significantly at 18 weeks' gestation in women who eventually develop preeclampsia (40) . The current studies demonstrate that plasma from preeclamptic women significantly up-regulates the expression of cell surface ICAM-1 in vascular endothelial cells. Oxidized LDL is known to cause endothelial cell activation and upregulation of ICAM-1 (41) . In addition, NF-κB activation plays an important role in the upregulation of ICAM-1 expression by binding to corresponding cis-regulatory elements in the promotor region of the ICAM-1 gene (16) . Given our findings that preeclamptic plasma activates NF-κB in endothelial cells, it is likely that increased lipid peroxides in preeclamptic plasma stimulate ICAM-1 expression through a NF-κB mediated mechanism. This hypothesis is supported by the findings that vitamin E and N-acetyl cystine not only inhibited endothelial cell NF-κB activation by preeclamptic plasma but also ICAM-1 expression. Conclusions about early pathogenic mechanisms in preeclampsia based on the results from this current study are limited by the fact that the plasma samples were obtained from patients who had preeclampsia. Consequently, our findings may be the result of other underlying pathogenic mechanisms leading to the development of this disease, and not the cause of preeclampsia.
A recent study by Chappell et al. revealed that supplementation with vitamins E and C of pregnant women at high risk for preeclampsia was beneficial in the prevention of preeclampsia (12) . In this prospective, randomized, placebo-controlled study, women at increased risk for preeclampsia received daily supplementation with 400 IU of vitamin E and 1000 mg of vitamin C beginning at 18-20 weeks gestation. Chappell et al. subsequently found a significantly decreased incidence of preeclampsia, from 18% in the placebo group to 8% in the treatment group. The rationale for using vitamin E and vitamin C in this study and the likely explanation of the observed beneficial effect was to decrease oxidative stress. That oxidative stress was decreased was demonstrated by decreased circulating 8-isoprostane levels in the treatment group (42) . The present study provides a potential molecular mechanism for the beneficial effects of antioxidant treatment for the prevention of preeclampsia. According to our data, plasma from women with preeclampsia activates NF-κB and upregulates ICAM-1 expression in endothelial cells in vitro. Furthermore, the addition of 50 µM vitamin E, a dose comparable with serum levels that result from taking 400 IU of vitamin E orally, inhibited NF-κB activation and significantly decreased ICAM-1 expression in endothelial cells cultured with preeclamptic plasma. Taken together, these studies support the hypothesis that, in part, the beneficial effect of antioxidant therapy in the prevention of preeclampsia is through the inhibition of lipid peroxide activation of vascular endothelial cells.
Elevated lipid peroxides in preeclampsia may mediate increased leukocyte adhesion to vascular endothelial cells, thus contributing to the pathophysiology of this disease. Oxidized low-density lipoprotein has been shown to increase endothelial cell expression of ICAM-1, vascular cell adhesion molecule 1, and E-selectin in vitro (43, 44) . Increased circulating levels of ICAM-1 are seen in patients with elevated triglycerides, atherosclerotic coronary artery disease, obesity, and hypertension, as well as preeclampsia (5, 45) . Monocyte and neutrophil adhesion to vascular endothelial cells is modulated by cell surface adhesion molecules, such as ICAM-1. Upregulation of endothelial cell ICAM-1 expression in preeclampsia may increase monocyte and neutrophil adherence to vascular endothelial cells. Because monocytes and neutrophils have increased superoxide production in preeclamptic women, the increased adherence and interaction of these activated leukocytes with the vascular endothelium could lead to further endothelial dysfunction and damage (46, 47) . Similar mechanisms for leukocyte-mediated endothelial dysfunction and damage have been proposed in the pathogenesis of atherosclerosis. The presence of acute atherosis in the spiral arteries of women with preeclampsia further supports the commonality between endothelial dysfunction in preeclampsia and atherosclerosis (21, 22) . These findings suggest that models of lipid peroxide-induced endothelial dysfunction in atherosclerosis may be useful in the study of endothelial dysfunction in preeclampsia.
In summary, severe preeclampsia is associated with elevated levels of circulating lipid peroxides. Plasma from preeclamptic women activates NF-κB and increases ICAM-1 expression in HUVEC. In addition, antioxidant treatment with vitamin E or N-acetyl-cysteine of HUVEC exposed to preeclamptic plasma inhibits NF-κB activation and ICAM-1 expression. These findings suggest that in preeclampsia, increased lipid peroxides upregulate ICAM-1 expression in vascular endothelial cells through a NF-κB mediated mechanism. Transfected HUVEC were treated with 5% preeclamptic plasma (N = 12) with or without 50 µM vitamin E for 48 h. NF-κB-induced luciferase activity was normalized to renilla luciferase activity. Results are expressed as an index of relative light units (RLU). Vitamin E reduced NF-κB activation by 77% compared with HUVEC treated with preeclamptic plasma without vitamin E (P<0.005). In addition, HUVEC were cultured with 5% plasma from severe preeclamptic patients (N = 5) for 48 h with or without vitamin. E. Analytic flow cytometric analysis was then performed for ICAM-1. Vitamin E reduced ICAM-1 expression significantly-by 39% compared with HUVEC treated with severe preeclamptic plasma without vitamin E (P<0.005). The data represent the means ± SEM. Transfected HUVEC were treated with 5% preeclamptic plasma (N = 5) with or without 5 mM NAC for 48 h. NF-κB-induced luciferase activity was normalized to renilla luciferase activity. Results are expressed as an index of relative light units (RLU). NAC reduced NF-κB activation by 75% compared with HUVEC treated with preeclamptic plasma without NAC (P<0.01). In addition, HUVEC were cultured with 5% plasma from severe preeclamptic patients (N = 5) for 48 h with or without NAC. Analytic flow cytometric analysis was then performed for ICAM-1. N-acetyl-cysteine reduced ICAM-1 expression significantly-by 62% compared with HUVEC treated with severe preeclamptic plasma without NAC (P<0.0001). The data represent the means ± SEM.
